Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated... | NCT03240991 | Trialant
CompletedObservationalUpdated Apr 17, 2018
Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)
ClinicalTrials.gov ID
NCT03240991
Lead Sponsor
Centre Hospitalier Universitaire de BesanconOTHER
Overall Status
Completed
Study Type
Observational
Enrollment
45Actual
Last Update Posted
Apr 17, 2018Actual
Start Date
Jul 11, 2016Actual
Primary Completion Date
Dec 1, 2016Actual
Completion Date
Dec 1, 2016Actual
Brief Summary
This study aims to describe quality of life in hereditary or acquired non drug-related bradykinin-mediated angioedema patients, using validated questionnaires
Angioedema
Quality of life
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinically documented angioedema due to C1 inhibitor deficiency, hereditary (type I et II) or acquired
Clinically documented angioedema with normal C1 inhibitor activity (hereditary type III)
Exclusion Criteria:
Acquired angioedema with normal C1 inhibitor activity (former "drug-induced")